Navigation Links
New Study Explores Medical Affairs Capabilities in Mature and High-Growth Markets
Date:8/23/2013

CHAPEL HILL, N.C., Aug. 23, 2013 /PRNewswire/ -- High-performing pharmaceutical and medical device companies are continually adjusting their Medical Affairs structures to cope with industry and market changes. As the global healthcare landscape continues to expand, Medical Affairs executives must build and maintain strong relationships with physicians and other key members of the medical community across the ever-growing worldwide marketplace.   

A new study by leading research and consulting firm Best Practices, LLC examines critical Medical Affairs capabilities in not only mature markets, but also emerging markets and India in particular. Medical Affairs has grown into a global function, especially in India where 89 percent of the companies that participated in the research study have established dedicated Medical Affairs groups in their organization.

To address the needs of Medical Affairs leaders in mature markets as well as developing markets, the study, "Building Best-in-Class Medical Affairs Capabilities In India- A Case Study For High-Growth Emerging Markets," provides executives with need-to-know comparative metrics, executive insights and best practices from Medical Affairs leaders throughout the healthcare industry.

Key topics addressed in the report will:

  • Illustrate How Leading Global and Indian Pharma & Medical Device Companies Structure & Organize Their Medical Affairs Functions Based On Industry & Market Changes
  • Identify Trends Expected To Impact The Allocation Of Resources Across Different Medical Affairs Functions.
  • Analyze How Regulatory Requirements Are Internalized And Managed By Medical Affairs.
  • Describe The Success Factors And Top Current Challenges Regarding Global & Indian Medical Affairs.
  • Identify What Percentage Of Medical Affairs Budget Leading Companies Allocate To Outsourcing.
  • Trace How Successful Medical Affairs Organizations Work Cross-Functionally To Enhance Effectiveness.

This benchmarking research drew participation from 68 Medical Affairs leaders at 50 top pharmaceutical and medical device companies across mature global markets. In addition, the study presents a segment from India-based organizations.

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1230.htm.

For more information on other recent primary research studies, contact us at 919.403.0251, or visit our website at http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study of Mechanism of Action of Ibrutinib in Mantle Cell Lymphoma Published in Blood - Journal of the American Society of Hematology
2. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
3. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
4. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
5. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
6. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
7. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
8. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
9. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
10. Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study
11. EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017 Quest Diagnostics (NYSE: ... diagnostic information services, today announced that it has been ... 2017 by Fortune. The annual survey ... in the "Health Care: Pharmacy and Other Services" industry ... information services company to attain the designation. This is ...
(Date:2/16/2017)... 2017 The Lockwood Group (Lockwood), a medical communications ... Work in Connecticut list by the ... in a row that Lockwood has been in the top ... number-two spot in 2017. The award recognizes companies that have ... were determined through a survey conducted by The Best Companies ...
(Date:2/16/2017)... 16, 2017 Summary Provides understanding and ... the worlds leading healthcare companies. ... Description The Global Allergy Partnering Terms and Agreements ... agreements entered into by the world,s leading healthcare companies. ... value - Deals listed by company A-Z, industry sector, stage ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network offers physicians ... controlled and non-controlled substances plus the ability to manage orders on their desktop ... now accept electronic prescriptions, according to the Office of the National Coordinator of ...
(Date:2/17/2017)... ... February 17, 2017 , ... Corrective Action & Preventive ... FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... and preventive action (PA)? , The methods share techniques and tools but they ...
(Date:2/17/2017)... ... 2017 , ... MAP Revenue Cycle Solutions (MAP RCS), a ... promoted to Chief Executive Officer. , The need for maximizing reimbursements while ... demands the transition from pay-for-service to pay-for-performance models. By delivering efficient and effective ...
(Date:2/17/2017)... ... ... Like most hospitals across the nation, Onslow Memorial Hospital is looking for more ... Program (HRRP), the return of a patient to the hospital within 30 days of ... providers are struggling to leverage limited resources and technology, Onslow Memorial Hospital has saved ...
(Date:2/16/2017)... York (PRWEB) , ... February 17, 2017 , ... ... determination. After what took over 10 years of research, development and clinical trials, ... Technology™. NTX Technology™ is a patented compound of FDA approved ingredients that when ...
Breaking Medicine News(10 mins):